Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Mahal

Showing results (91-100 of 210) with videos related to

Pageof 21
Sort By:
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
American Journal of Clinical Oncology|January 7, 2020
Early Impact of the Affordable Care Act and Medicaid Expansion on Racial and Socioeconomic Disparities in Cancer CareAmandeep R Mahal, Janice Chavez, David D Yang, et al.
Cancer|August 9, 2016
Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumorsSarah C Markt, Carlos A Lago-Hernandez, Rowan E Miller, et al.
The Journal of Urology|May 31, 2019
Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate CancerVinayak Muralidhar, Brandon A Mahal, Santino Butler, et al.
The Prostate|July 14, 2020
Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial prioritiesEdward Christopher Dee, Michelle D Nezolosky, Fallon E Chipidza, et al.
Clinical Genitourinary Cancer|December 15, 2022
Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent OutcomeNishwant Swami, Tiffany Nguyen, Ifeanyichukwu Ogobuiro, et al.
Clinical Genitourinary Cancer|June 30, 2015
Association Between Older Age and Increasing Gleason ScoreVinayak Muralidhar, David R Ziehr, Brandon A Mahal, et al.
The Lancet Regional Health. Western Pacific|February 14, 2023
Disparities in access to cancer diagnostics in ASEAN member countriesNicole Rose I Alberto, Isabelle Rose I Alberto, Corinna Victoria M Puyat, et al.
JAMA Network Open|November 1, 2023
Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-AnalysisBrandon A Mahal, Lucia Kwak, Wanling Xie, et al.
European Urology Oncology|June 6, 2019
Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical ImplicationsMohammed Alshalalfa, Paul L Nguyen, Himisha Beltran, et al.
Pageof 21

Showing results (91-100 of 210) with videos related to

Sort By:
Pageof 21
Clinical Genitourinary Cancer|September 8, 2020
Development and Validation of a Novel TP53 Mutation Signature That Predicts Risk of Metastasis in Primary Prostate CancerFallon E Chipidza, Mohammed Alshalalfa, Brandon A Mahal, et al.
American Journal of Clinical Oncology|January 7, 2020
Early Impact of the Affordable Care Act and Medicaid Expansion on Racial and Socioeconomic Disparities in Cancer CareAmandeep R Mahal, Janice Chavez, David D Yang, et al.
Cancer|August 9, 2016
Insurance status and disparities in disease presentation, treatment, and outcomes for men with germ cell tumorsSarah C Markt, Carlos A Lago-Hernandez, Rowan E Miller, et al.
The Journal of Urology|May 31, 2019
Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate CancerVinayak Muralidhar, Brandon A Mahal, Santino Butler, et al.
The Prostate|July 14, 2020
Prostate cancer-specific mortality burden by risk group among men with localized disease: Implications for research and clinical trial prioritiesEdward Christopher Dee, Michelle D Nezolosky, Fallon E Chipidza, et al.
Clinical Genitourinary Cancer|December 15, 2022
Distinct Profiles of DNA Repair Activity Define Favorable-risk Prostate Cancer Subtypes With Divergent OutcomeNishwant Swami, Tiffany Nguyen, Ifeanyichukwu Ogobuiro, et al.
Clinical Genitourinary Cancer|June 30, 2015
Association Between Older Age and Increasing Gleason ScoreVinayak Muralidhar, David R Ziehr, Brandon A Mahal, et al.
The Lancet Regional Health. Western Pacific|February 14, 2023
Disparities in access to cancer diagnostics in ASEAN member countriesNicole Rose I Alberto, Isabelle Rose I Alberto, Corinna Victoria M Puyat, et al.
JAMA Network Open|November 1, 2023
Mortality Risk for Docetaxel-Treated, High-Grade Prostate Cancer With Low PSA Levels: A Meta-AnalysisBrandon A Mahal, Lucia Kwak, Wanling Xie, et al.
European Urology Oncology|June 6, 2019
Transcriptomic and Clinical Characterization of Neuropeptide Y Expression in Localized and Metastatic Prostate Cancer: Identification of Novel Prostate Cancer Subtype with Clinical ImplicationsMohammed Alshalalfa, Paul L Nguyen, Himisha Beltran, et al.
Pageof 21